Orgasm is a sensation of intense pleasure accompanied by contractions of the pelvic, uterine / anal musculature and myotonia that determines the sexually induced vasocongest, leading to well-being and satisfaction. Anorgasmia, the second sex problem most frequently reported among women, is considered a persistent or recurrent delay in the lack of orgasm followed by a sexual arousal phase that causes marked distress or interpersonal difficulties (DSM-IV). Research on the outcome of empirical treatment is assessed by pharmacological approach and cognitive behavior. Cognitive behavioral therapy for anorgasmia promotes changes in attitude and sexual thinking, reduction of anxiety using behavioral exercises such as direct masturbation and treatment of systematic desensitization, as well as sex education, Kegel exercises and use of vibrators. So far, there are no drugs (eg, bupropion, l-arginine, and sildenafil) that have been shown to have a greater beneficial effect than placebos in increasing orgasmic function in women with anorgasmia. More research is needed to understand the conduct of women with orgasmic dysfunction. ; Orgasm is a feeling of intense pleasure accompanied by pelvic striated circumvaginal musculature and uterine / anal contractions and myotonia that involves sexually-induced vasocongestion, inducing well-being and contentment. Female Orgasmic Disorder, the second most frequently reported women's sexual problem is considered to be the persistent or recurrent delay in or orgasm following normal sexual excitement phase that causes marked distress or interpersonal difficulty (DSM-IV). Empirical treatment outcome is available for cognitive behavioral and pharmacological approaches. Cognitive-behavioral therapy for anorgasmia promotes attitude and sexually-relevant thought changes and anxiety reduction using behavioral exercises such as directed masturbation and systematic desensitization treatments as well as sex education, communication skills training and Kegel exercises. To date there are in the pharmacological agents trials (ie, bupropion, l-arginine, and sildenafil) proven to be beneficial beyond placebo in enhancing orgasmic function in women diagnosed with Female Orgasmic Disorder. More research is needed in understanding management of women with orgasmic dysfunction.
|Translated title of the contribution||Treatment of anorgasmia|
|Number of pages||5|
|Journal||Revista Brasileira de Sexualidade Humana|
|Publication status||Published - 2005|
- female orgasm
- sexual dysfunction
- pharmacological agents